Illumina, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4523271090
USD
123.79
-0.54 (-0.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Halozyme Therapeutics, Inc.
Amgen, Inc.
Illumina, Inc.
Gilead Sciences, Inc.
Moderna, Inc.
Bio-Techne Corp.
BioMarin Pharmaceutical, Inc.
Biogen, Inc.
Elanco Animal Health, Inc.
Vaxcyte, Inc.
Immunovant, Inc.

Why is Illumina, Inc. ?

1
Company has a low Debt to Equity ratio (avg) at times
2
Poor long term growth as Operating profit has grown by an annual rate 9.08% of over the last 5 years
3
The company has declared Positive results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 1,079 MM
  • INTEREST COVERAGE RATIO(Q) Highest at 1,246.15
  • RAW MATERIAL COST(Y) Fallen by -1.74% (YoY)
4
With ROCE of 28.32%, it has a fair valuation with a 7.39 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 41.22%, its profits have risen by 50.2% ; the PEG ratio of the company is 0.6
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Market Beating Performance
  • The stock has generated a return of 41.22% in the last 1 year, much higher than market (S&P 500) returns of 16.12%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Illumina, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Illumina, Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Illumina, Inc.
41.22%
0.33
48.99%
S&P 500
16.12%
0.84
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
6.03%
EBIT Growth (5y)
9.08%
EBIT to Interest (avg)
5.03
Debt to EBITDA (avg)
1.05
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.89
Tax Ratio
8.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
14.04%
ROE (avg)
8.97%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
8.41
EV to EBIT
26.09
EV to EBITDA
20.02
EV to Capital Employed
7.39
EV to Sales
5.37
PEG Ratio
0.64
Dividend Yield
NA
ROCE (Latest)
28.32%
ROE (Latest)
23.44%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 1,079 MM

INTEREST COVERAGE RATIO(Q)

Highest at 1,246.15

RAW MATERIAL COST(Y)

Fallen by -1.74% (YoY

NET SALES(Q)

Highest at USD 1,160 MM

OPERATING PROFIT(Q)

Highest at USD 324 MM

OPERATING PROFIT MARGIN(Q)

Highest at 27.93 %

PRE-TAX PROFIT(Q)

Highest at USD 226 MM

NET PROFIT(Q)

Highest at USD 199.69 MM

EPS(Q)

Highest at USD 2.17

-5What is not working for the Company
NET PROFIT(HY)

At USD 348.33 MM has Grown at -50.31%

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.31 times

Here's what is working for Illumina, Inc.

Operating Cash Flow
Highest at USD 1,079 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Interest Coverage Ratio
Highest at 1,246.15
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales
Highest at USD 1,160 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 324 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 27.93 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 226 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 199.69 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 2.17
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -1.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Illumina, Inc.

Debtors Turnover Ratio
Lowest at 5.31 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio